Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry Letters|June 20, 2008
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonistsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compoundWilliam T McElroy, Zheng Tan, Kallol Basu, et al.
European Journal of Pharmacology|December 29, 1995
In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsS D Kivlighn, G J Zingaro, R A Gabel, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ringYan Xia, Samuel Chackalamannil, Martin Clasby, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2006
Tetrahydroquinoline sulfonamides as gamma-secretase inhibitorsTheodros Asberom, Thomas A Bara, John W Clader, et al.
Journal of Medicinal Chemistry|April 2, 2005
Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeuticsMark D McBriar, Henry Guzik, Ruo Xu, et al.
Neurobiology of Disease|September 16, 2018
Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's diseaseNajiba Mammadova, Corey M Summers, Robyn D Kokemuller, et al.
BMC Research Notes|October 1, 2011
Evaluation of two sets of immunohistochemical and Western blot confirmatory methods in the detection of typical and atypical BSE casesChiara Porcario, S Mark Hall, Francesca Martucci, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2012
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophreniaGinny D Ho, W Michael Seganish, Ana Bercovici, et al.
Pageof 30